8-K: BioRegenx Terminates BF Borgers as Independent Auditor Amidst SEC Restrictions
Current Report
BioRegenx, Inc. has dismissed BF Borgers CPA PC as its independent registered public accounting firm, effective May 15, 2024, due to the firm's inability to practice before the SEC.
Summary
- BioRegenx, Inc. has terminated BF Borgers CPA PC as their independent registered public accounting firm on May 15, 2024.
- The decision to dismiss BF Borgers was unanimously approved by the company's audit committee.
- There were no disagreements between BioRegenx and BF Borgers regarding accounting principles, financial statement disclosure, or auditing scope.
- BF Borgers is currently not permitted to practice before the Securities and Exchange Commission (SEC).
- Due to BF Borgers' inability to practice before the SEC, BioRegenx will not be requesting a letter from BF Borgers to the SEC regarding the statements made in this report.
Sentiment
Score: 3
Explanation: The sentiment is negative due to the dismissal of the auditor and the potential disruption it may cause. The fact that the auditor is not permitted to practice before the SEC is a significant concern.
Positives
- The company's audit committee unanimously approved the decision to change auditors.
- There were no disagreements with the previous auditor regarding accounting or auditing matters.
Negatives
- The company had to dismiss their auditor due to the firm's inability to practice before the SEC.
Risks
- The company needs to find a new independent registered public accounting firm that is permitted to practice before the SEC.
- The change in auditors could potentially cause delays in future financial reporting.
Management Comments
- The company's audit committee unanimously approved the decision to dismiss BF Borgers.
Industry Context
The dismissal of BF Borgers highlights the importance of auditor compliance with SEC regulations and the potential impact on companies if their auditors are restricted from practicing before the SEC. This situation is not unique and other companies may face similar issues if their auditors are sanctioned by the SEC.
Comparison to Industry Standards
- The dismissal of an auditor due to SEC restrictions is not uncommon, but it does require a company to quickly find a replacement that meets regulatory requirements.
- Companies typically engage large, reputable accounting firms to avoid such issues, and the fact that BioRegenx was using BF Borgers, a firm that is now restricted, suggests they may have been using a smaller or less established firm.
- Other companies that have faced similar situations include those that have had their auditors sanctioned for various reasons, such as accounting irregularities or lack of independence.
Stakeholder Impact
- Shareholders may be concerned about the change in auditors and the potential impact on financial reporting.
- The company will need to ensure a smooth transition to a new auditor to maintain investor confidence.
Next Steps
- BioRegenx needs to engage a new independent registered public accounting firm that is permitted to practice before the SEC.
Key Dates
| Date | Description |
|---|---|
| May 15, 2024 | Date of dismissal of BF Borgers as independent auditor. |
| May 16, 2024 | Date of the 8-K filing. |
Keywords
auditor, accounting firm, BF Borgers, independent auditor, SEC, audit committee, financial statements
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.